Navigation Links
New Order Issued in GYNECARE PROLIFT Transvaginal Mesh Lawsuit Consolidation Ensures Cases Move Forward, Rottenstein Law Group LLP Reports

(PRWEB) January 10, 2014

A Jan. 7 protective order issued in federal court in West Virginia will ensure that Ethicon GYNECARE PROLIFT vaginal mesh lawsuits move forward, according to court documents. The Rottenstein Law Group LLP, which maintains a GYNECARE PROLIFT informational website at, explains Judge Joseph R. Goodwin’s order for those who have filed or are looking to file vaginal mesh lawsuits.

Nonparties who were served with subpoenas to produce documents can now designate those documents as “Confidential/Highly Confidential,” according to the order (In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation; MDL-2327, U.S. District Court for the Southern District of West Virginia).

There are currently almost 12,000 Ethicon lawsuits pending in a consolidation of federal court cases, referred to as a “multidistrict litigation,” according to court documents. Federal vaginal mesh lawsuits involving six different manufacturers were all consolidated into U.S. District Court before Goodwin for the purpose of pretrial efficiency.

“The documents will be protected, only to be viewed by lawyers,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “With a protective order in place, the nonparties can be assured of the continued confidentiality of the documents demanded. Now they can produce the documents, discovery can continue and the lawsuits can move along.”

Bellwether trials are planned for 2014, with the first scheduled to begin on Feb. 10, according to court documents.

There has already been at least one Ethicon trial in state courts. In March 2013, a jury awarded more than $11 million to plaintiff Linda Gross in New Jersey Superior Court, according to court documents (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey).
There are five MDL defendants, except for Ethicon, who are reportedly considering vaginal mesh settlements, according to a Sept. 30 Bloomberg article.*

Women are filing transvaginal mesh lawsuits alleging they suffered injuries such as pain, discomfort and the erosion of the mesh implant, according to court documents. There are more than 40,000 transvaginal mesh injury lawsuits pending in the six MDLs, according to court documents.

The Rottenstein Law Group LLP encourages women who believe they have suffered from the alleged side effects of their transvaginal mesh implants to visit the firm's GYNECARE PROLIFT Mesh Lawsuit Center FAQ page to learn more about vaginal mesh settlements and lawsuits, and to apply for a free case review. For updates on lawsuit news, visit RLG's transvaginal mesh Facebook page.


The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
100 Merrick Road
# 266
Rockville Centre, NY 11570
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Ethicon Transvaginal Mesh Lawsuit Update: Bernstein Liebhard LLP Notes Issuance of New Order in Federal Ethicon Mesh Litigation
2. Mental disorders in mid-life and older adulthood more prevalent than previously reported
3. Federal Judge Orders Review of C.R. Bard Avaulta Vaginal Mesh Lawsuits, Rottenstein Law Group LLP Reports
4. Federal Judge Orders Updated Accounting in Bard Avaulta Vaginal Mesh Lawsuits, Rottenstein Law Group LLP Reports
5. Phobia Release Program Review
6. How This Program Helps People Get Rid of Their Social Anxiety Disorders Easily – Vinamy
7. Mirena IUD Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in New Jersey Mirena Lawsuits
8. Idol Lash Eyelash Growth Serum Now Offers Extra Discount on All Orders as New Year Special
9. Bowtrol Colon Cleansing Treatment Now Offers Extra Discount on All Orders as New Year Special
10. Tava Tea: An Organic Weight Loss Green Tea Now Offers Massive Discount on All Orders As New Year Special
11. Venapro Hemorrhoids Relief Treatment Now Offers Extra Discount on All Orders as New Year Special
Post Your Comments:
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: